Intelgenx Technologies Stock

Intelgenx Technologies Liabilities 2024

Intelgenx Technologies Liabilities

20.53 M USD

Ticker

IGX.TO

ISIN

US45822R1014

WKN

A0RP0X

In 2024, Intelgenx Technologies's total liabilities amounted to 20.53 M USD, a 62.8% difference from the 12.61 M USD total liabilities in the previous year.

Intelgenx Technologies Aktienanalyse

What does Intelgenx Technologies do?

IntelGenx Technologies Corp is a Canadian company specializing in the development and manufacturing of orally dissolving films and other innovative pharmaceutical products. The company was founded in 2003 and has been listed on the Toronto Stock Exchange (TSX) since 2007. IntelGenx's history began with the development of a novel technology for the production of orally dissolving films called Versatile Film Technology (VFT). This technology allows for the creation of films that can administer active ingredients quickly and effectively without the need to be swallowed. Over the years, the company has evolved and expanded its product range to enable other innovative pharmaceutical formulations as well. IntelGenx's business model is based on licensing its technology and products to pharmaceutical companies and other organizations in the industry. The company offers a range of services, including formulation development, GMP-compliant product manufacturing, and support in submitting regulatory applications to the relevant authorities. IntelGenx is divided into several divisions tailored to the specific needs of its customers. The main division of the company is the production of orally dissolving films marketed under the brand name VersaFilm. These films are produced in various strengths and formulations and can be used for a variety of medical applications. Another significant division of IntelGenx is the development of products based on cannabinoids. The company has partnered with Tilray, a leading medical cannabis manufacturer, to develop a range of cannabinoid-based products available as orally dissolving films or capsule-based formulations. In addition to these two main divisions, IntelGenx also offers services in the field of polymer-based drug delivery. The company has partnered with a major pharmaceutical company to develop a variety of products based on this technology that can be used to treat diseases such as Alzheimer's and Parkinson's. Another important product offered by IntelGenx is the Sildenafil Oral Film, used to treat erectile dysfunction. This prescription medication is available in the United States and Canada and is considered a fast and convenient alternative to traditional formulations. In summary, IntelGenx Technologies Corp is an innovative company specializing in the development and manufacturing of orally dissolving films and other pharmaceutical products. The company's Versatile Film Technology (VFT) is a cutting-edge technology that allows for the quick and effective administration of active ingredients, and the company has developed a wide range of products and services to meet the needs of its customers. Intelgenx Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Intelgenx Technologies's Liabilities

Intelgenx Technologies's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Intelgenx Technologies's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Intelgenx Technologies's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Intelgenx Technologies's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Intelgenx Technologies’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Intelgenx Technologies stock

What is the level of liabilities of Intelgenx Technologies this year?

Intelgenx Technologies has a debt balance of 20.53 M USD this year.

What were the liabilities of Intelgenx Technologies compared to the previous year?

The liabilities of Intelgenx Technologies have increased by 62.8% increased compared to the previous year.

What are the consequences of high debt for investors of Intelgenx Technologies?

High liabilities can pose a risk for investors of Intelgenx Technologies, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Intelgenx Technologies?

Low liabilities mean that Intelgenx Technologies has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Intelgenx Technologies affect the company?

An increase in liabilities of Intelgenx Technologies can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Intelgenx Technologies affect the company?

A decrease in the liabilities of Intelgenx Technologies can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Intelgenx Technologies?

Some factors that can influence the liabilities of Intelgenx Technologies include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Intelgenx Technologies so important for investors?

The liabilities of Intelgenx Technologies are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Intelgenx Technologies take to modify the liabilities?

To change its liabilities, Intelgenx Technologies can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Intelgenx Technologies pay?

Over the past 12 months, Intelgenx Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intelgenx Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of Intelgenx Technologies?

The current dividend yield of Intelgenx Technologies is .

When does Intelgenx Technologies pay dividends?

Intelgenx Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intelgenx Technologies?

Intelgenx Technologies paid dividends every year for the past 0 years.

What is the dividend of Intelgenx Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intelgenx Technologies located?

Intelgenx Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intelgenx Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intelgenx Technologies from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Intelgenx Technologies pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Intelgenx Technologies in the year 2023?

In the year 2023, Intelgenx Technologies distributed 0 USD as dividends.

In which currency does Intelgenx Technologies pay out the dividend?

The dividends of Intelgenx Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Intelgenx Technologies stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Intelgenx Technologies

Our stock analysis for Intelgenx Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intelgenx Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.